Webinar

Significance, Assessment and Treatment of Head and Neck Lymphedema


Dr. Bhayani shares best practices for identifying and treating patients with head and neck lymphedema (HNL) using case studies and recent clinical data:

  • With the growing number of cancer survivors, pre-habilitation and rehabilitation are increasingly important in cancer care.
  • Up to 90% of head and neck cancer survivors suffer from HNL.
  • Flexitouch┬« Plus pneumatic compression device is clinically proven to improve patients HNL symptoms.1

1Ridner, S.H. et al. Support Care Cancer (2020)

Click the timestamps below to jump to video segments on YouTube:

0:00 Intro

2:35 Trends in HN Cancer: the importance of HPV

9:39 The biggest risks in HNC cancer survivorship

14:35 Lymphedema – prevalence and presentation

16:33 New clinical data: Internal lymphedema persists in the long term

20:18 Diagnosing lymphedema through imaging

22:47 Treating HN lymphedema and introduction to Flexitouch

25:26 Clinical evidence of Flexitouch improvements

30:40 Real life evidence of Flexitouch improvements

34:00 The correlation between external and internal lymphedema?

35:35 In Summary – We need to focus on survivorship

37:23 Barriers to treating lymphedema

39:58 Cancer care team treating lymphedema

42:02 Introduction to Patient Gail

44:25 Patient Gail’s testimonial

49:24 Q&A Session: When do you diagnose lymphedema? Send to therapy? Refer Flexitouch?

Presented By

  • Mihir K. Bhayani, MD, FACS